Saturday 17 October 2026
Export AUNA’s income statement to Excel — free account
Auna S.A.
AUNA Healthcare Medical Care Facilities
Auna S.A.’s revenue for fiscal 2025 (year ended December 2025) was $1.2 billion, up 5.27% from fiscal 2024. In the quarter to June 2026, revenue grew 20.5%, EPS fell 61.3%, free cash flow grew 121.1% and total debt rose 7.31%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
5.32
0.02
+0.38%
Follow AUNA
| Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|
Piotroski F-Score |
— | — | 5 |
P/E ratio |
18.05 | 18.05 | 13.67 |
Altman Z-Score |
— | 1.08 | 1.02 |
P/S ratio |
0.00 | 0.40 | 0.30 |
Altman Z″-Score (non-manufacturers) |
0.53 | 0.71 | 0.98 |
P/FCF ratio |
0.00 | 3.29 | 2.48 |
Beneish M-Score |
— | (2.81) | (2.69) |
P/Operating CF |
0.00 | 8.93 | 5.94 |
P/B ratio |
0.00 | 1.07 | 0.73 |
Price to Tangible BV |
0.00 | 0.00 | 0.00 |
EV/Sales |
0.00 | 1.17 | 1.04 |
EV/EBITDA |
0.00 | 5.25 | 5.56 |
EV/Operating CF |
0.00 | 7.66 | 6.88 |
EV/FCF |
0.00 | 9.72 | 8.69 |
Quick Ratio |
0.71 | 0.67 | 0.84 |
Current Ratio |
0.92 | 0.88 | 1.11 |
Net Debt/EBITDA |
4.62 | 3.48 | 3.98 |
Debt/Assets |
50.56% | 52.75% | 49.69% |
Debt/Equity |
2.19 | 2.30 | 2.05 |
Asset Turnover |
0.00 | 0.59 | 0.63 |
Operating CF/Net income |
(2.29) | 6.06 | 6.79 |
Capex/Depreciation |
(0.77) | (0.74) | (0.71) |
Interest Coverage |
0.71 | 1.32 | 0.96 |
| 0.00% | 6.48% | 5.90% | |
| 0.00% | 1.49% | 1.39% | |
ROIC |
6.57% | 9.77% | 7.77% |
Return on Tangible Assets |
(10.44%) | 5.41% | 3.96% |
Average Days of Receivables |
81.07 | 80.05 | 86.79 |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
23.18% | 22.48% | 23.57% |
Intangible Assets out of Total Assets |
0.41 | 0.38 | 0.37 |
Share Based Compensation of Revenue |
0.09% | 0.21% | 0.26% |
Graham Net Nets |
0.00 | (2.17) | (2.84) |
Graham Number |
0.00 | 7.41 | 7.37 |
Earnings Yield |
5.54% | 5.54% | 7.32% |
Free Cash Flow Yield |
0.00% | 30.40% | 40.40% |
Revenue per Share |
23.60 | 17.36 | 16.63 |
Operating CF per Share |
3.55 | 2.65 | 2.51 |
Capex per Share |
(0.98) | (0.56) | (0.52) |
Free Cash Flow per Share |
2.57 | 2.09 | 1.99 |
Cash per Share |
2.04 | 1.37 | 1.39 |
Shareholders Equity per Share |
10.82 | 6.42 | 6.70 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 |
Book value per Share |
10.82 | 6.42 | 6.70 |
Free Cash Flow |
112.69 | 140.41 | 147.13 |
Working Capital |
(37.48) | (64.33) | 49.80 |
Capital Expenditures |
(43.04) | (37.75) | (38.77) |
Net Current Asset Value |
(1,166.89) | (1,000.42) | (1,034.61) |
EV/EBIT |
0.00 | 6.54 | 7.29 |
Capex to Sales |
0.04 | 0.03 | 0.03 |
Price to Operating Income |
0.00 | 2.21 | 2.08 |
| Other line items | |||
Depreciation/Fixed assets |
0.08 | 0.08 | 0.08 |
Cash ROIC |
7.02% | 9.24% | 9.10% |
Accounts Receivable Turnover |
0.00 | 4.80 | 4.48 |
Accounts Payable Turnover |
0.00 | 3.16 | 2.81 |
Inventory Turnover |
0.00 | 19.37 | 18.06 |
Average Days of Payables |
112.07 | 127.75 | 141.27 |
Days of Inventory on Hand |
19.52 | 19.72 | 22.10 |
Average Receivables |
— | 243.28 | 274.48 |
Average Payables |
— | 224.28 | 271.88 |
Average Inventory |
— | 36.61 | 42.28 |
Average Assets |
— | 1,971.60 | 1,967.42 |
Average Common Equity |
— | 453.78 | 464.08 |
Columns are period end dates